Renal endothelial function in humans

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 2, 1998, Pages 149-152

  Mimran, Albert ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY EPITHELIUM; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ALBUMINURIA; ARGININE; ENDOTHELIUM; ENZYME INHIBITORS; HUMANS; HYPERTENSION; KIDNEY; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE;

EID: 0031907070     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199803000-00002     Document Type: Article

References (32)

1. Diamond JR, Kamovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33:917-924.
2. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1298-1303.
3. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87:1475-1481.
4. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91:1981-1987.
5. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 1992; 42:1017-1019.
6. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 1995; 268:F885-F898.
7. Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abrams HL, Merrill JP. Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309-317.
8. Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, Merrill JP. Renal vascular tone in essential and secondary hypertension. Medicine 1975; 54:29-44.
9. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20:511-517.
10. Smulders RA, Stehouwer CDA, Olthof CG, VanKamp GJ, Teerlink T, DeVries PMJM, Donker AJM. Plasma endothelin levels and vascular effects of intravenous L-arginine in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994; 87:37-43.
11. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-Arginine infusion induces hypotension and diuresis natriuresis with con-comitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992; 19:619-625.
12. Bijlsma JA, Rabelink AJ, Kaasjager KAH, Koomans HA. L-Arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 1995; 5:1508-1516.
13. Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T. Direct measurement of nitric oxide in human beings. Lancet 1995; 346:153-154.
14. Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frolich JC. L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994; 87:303-310.
15. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D. D'Onofrio F. The vascular effect of L-arginine in humans. The role of endogenous insulin. J Clin Invest 1997; 99:433-438. In this study, the role of the L-arginine-induced stimulation of insulin release on the leg dilatory action of L-arginine was tested through the prevention of insulin release by the somatostatin analogue octreotide. In this condition, the vascular response of L-arginine was blunted, thus suggesting that endogenous insulin partly mediates the effect of L-arginine.
16. Hirschberg R, Kopple JD. Role of growth hormone in the amino acid-induced acute rise in renal function in man. Kidney Int 1987; 32:382-387.
17. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30 (pt 1):252-258.
18. Mimran A, Ribstein J, Du Cailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995; 26 (pt 1):937-941.
19. Castellino P, Coda B, DeFronzo RA. Effect of aminoacid infusion on renal hemodynamics in humans. Am J Physiol 1986; 251:F132-F140.
20. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2:997-1000.
21. Na, and vasoactive hormones in healthy humans. Am J Physiol 1996; 270:F845-F851.
22. Dijkhorst-Oei LT, Rabelink TJ, Boer P, Koomans HA. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans. Hypertension 1997; 29:1192-1198.
23. 9-monomethyl-L-arginine in normal volunteers.
24. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 81:695-700.
25. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349:837-842. In this study, it is shown that the whole-body production of NO is deficient in basal conditions in patients with essential hypertension. An inverse correlation between total urinary excretion of nitrate, measured by mass spectrometry and mean daytime ambulatory arterial pressure, was obtained.
26. Goonasekera CDA, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997; 15:901-909.
27. Pedrinelli R, Giampietro O, Melillo E, Dellomo G, Catapano G, Matteucci E, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344:14-18.
28. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Arrighi P, Salvetti A. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. J Hypertens 1995; 13:1003-1008.
29. Elliot TG, Cockrott JR, Groop PH, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in the forearm vasculature of insulin-dependent diabetic patients blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85:687-693.
30. Mimran A, Ribstein J, Du Cailar G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994, 23 (pt 2):1018-1021.
31. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. JACC 1993; 21:1145-1151.
32. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24:499-505.